Enrolling by Invitation
GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer
NCT07316361
- Conditions
- Endometrial Carcinoma, Endometrial Carcinoma Stage III, Endometrial Neoplasms, +11 more
- Locations
-
- Biogenea Pharmaceuticals Ltd & Interbalkan Medical Center - International Oncology Center Thessaloniki, Greece